Related Experiment Video
Updated: Jun 26, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Financial Toxicity: Inequities and Impact on Cardiovascular Disease
Clarke Morihara1, Kevin Benavente1, Charlotte Park1
1Department of Medicine, John A. Burns School of Medicine, University of Hawai'i, Honolulu (C.M., K.B., C.P.).
Rising healthcare costs lead to financial toxicity, negatively impacting cardiovascular disease outcomes. Addressing financial strain through policy and advocacy is crucial for public health and patient well-being.
Area of Science:
- Public Health
- Health Economics
- Cardiology
Background:
- Healthcare costs are escalating globally, disproportionately affecting various socioeconomic groups.
- Financial strain and financial toxicity are emerging consequences of rising medical expenses and economic instability.
- These financial burdens have significant, detrimental effects on cardiovascular disease (CVD) prevalence and management.
Purpose of the Study:
- To review the concept of financial toxicity in the context of cardiovascular disease.
- To explore the interplay between net worth, financial mobility, social determinants of health, and CVD.
- To examine the role of public health advocacy and policy interventions in mitigating financial toxicity.
Main Methods:
- This study is a comprehensive literature review.
- It synthesizes existing research on financial toxicity, socioeconomic factors, and cardiovascular health.
- The review analyzes policy and advocacy strategies relevant to public health interventions.
Main Results:
- Financial toxicity is a significant multidimensional issue impacting cardiovascular disease.
- Socioeconomic factors like net worth and financial mobility are closely linked to CVD outcomes.
- Social determinants of health exacerbate the financial burden on patients with cardiovascular conditions.
Conclusions:
- Understanding financial toxicity is essential for improving population-wide cardiovascular health outcomes.
- Integrated approaches addressing financial strain, socioeconomic factors, and social determinants are necessary.
- Policy and advocacy efforts are critical components of public health strategies to combat financial toxicity in cardiovascular disease.
Related Concept Videos
Coronary Artery Disease I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure I: Introduction
Cardiovascular Drugs: Classification based on Therapeutic Indications
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...